drugset / Trial / NCT00171184
Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to assess the efficacy, safety and tolerability of 12-weeks treatment with darifenacin in patients aged \>Ý 65 years with OAB.
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darifenacin | Small molecule | 7.5 mg | — |
| Subject | Darifenacin | Small molecule | 15 mg | — |